Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE152856 |
YAP promotes cardiomyocyte cell cycle entry
|
6 | Jong H Kim | Jan 11, 2024 | ||||
GSE192630 |
Activin A marks a novel progenitor cell population during fracture healing and reveals a therapeutic strategy
|
3 | Lutian Yao | Jan 11, 2024 | ||||
GSE205926 |
Effect of Pax6 KO in mouse conjunctival organoids
|
5 | Marie Bannier-Hélaouët | Jan 11, 2024 | ||||
GSE211845 |
Maternal KLF17 regulates zygotic genome activation in the mouse
|
77 | Wenjie Shu | Jan 11, 2024 | ||||
GSE217828 |
YAP Drives Assembly of a Spatially Colocalized Cellular Triad Required for Heart Renewal
|
12 | Jong H Kim | Jan 11, 2024 | ||||
GSE222625 |
MyD88 deficiency in podocytes does not change the outcome in experimental glomerulonephritis.
|
11 | Giuliano Crispatzu | Jan 11, 2024 | ||||
GSE227905 |
Single Cell sequencing analysis of intrapulmonary airway cells from wildtype mouse and Sox2 conditional knockout mouse
|
2 | Michael Patrick Morley | Jan 11, 2024 | ||||
GSE233779 |
NIC/VC and NIC/p66 mammary tumors
|
12 | Claudia L Kleinman | Jan 11, 2024 | ||||
GSE236823 |
Acquisition of suppressive function by CD4+ conventional T cells limits anti-tumor immunity driven by Treg depletion [RNA-seq]
|
8 | Rahul Roychoudhuri | Jan 11, 2024 | ||||
GSE236824 |
Acquisition of suppressive function by CD4+ conventional T cells limits anti-tumor immunity driven by Treg depletion [scRNA-seq]
|
6 | Rahul Roychoudhuri | Jan 11, 2024 | ||||
GSE236825 |
Acquisition of suppressive function by CD4+ conventional T cells limits anti-tumor immunity driven by Treg depletion.
|
27 | Rahul Roychoudhuri | Jan 11, 2024 | ||||
GSE237140 |
Acquisition of suppressive function by CD4+ conventional T cells limits anti-tumor immunity driven by Treg depletion [RNA-seq II]
|
13 | Rahul Roychoudhuri | Jan 11, 2024 | ||||
GSE243466 |
Single cell RNA profiling of neutrophils in a model of pancreatic orthotopic cancer
|
2 | Laiguan Ng | Jan 11, 2024 | ||||
GSE244202 |
Tuft cells and fibroblasts promote thymus regeneration through activation of a type-2 immune response [ILC2_after_irr]
|
20 | Jakub Abramson | Jan 11, 2024 | ||||
GSE244216 |
Tuft cells and fibroblasts promote thymus regeneration through activation of a type-2 immune response [ILC2_after_Dex]
|
33 | Jakub Abramson | Jan 11, 2024 | ||||
GSE244217 |
Tuft cells and fibroblasts promote thymus regeneration through activation of a type-2 immune response [Fibroblasts_after_irr]
|
15 | Jakub Abramson | Jan 11, 2024 | ||||
GSE244218 |
Tuft cells and fibroblasts promote thymus regeneration through activation of a type-2 immune response [Fibroblasts_after_Dex]
|
11 | Jakub Abramson | Jan 11, 2024 | ||||
GSE244219 |
Tuft cells and fibroblasts promote thymus regeneration through activation of a type-2 immune response [Tuft_after_irr]
|
9 | Jakub Abramson | Jan 11, 2024 | ||||
GSE244220 |
Tuft cells and fibroblasts promote thymus regeneration through activation of a type-2 immune response [Tuft_after_Dex]
|
21 | Jakub Abramson | Jan 11, 2024 | ||||
GSE244221 |
Tuft cells and fibroblasts promote thymus regeneration through activation of a type-2 immune response [NKT_after_Dex]
|
14 | Jakub Abramson | Jan 11, 2024 |